354
Participants
Start Date
October 31, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
December 31, 2010
Oral treprostinil (UT-15C) sustained release tablets
UT-15C 0.25, 0.5, 1, or 5 mg oral tablets by mouth every 12 hours
Placebo
Placebo 0.25, 0.5, 1, or 5 mg oral tablets by mouth every 12 hours
Columbia Presbyterian Medical Center, New York
Mary M Parkes Center for Asthma, Allergy and Pulmonary Care, Rochester
Allegheny General Hospital, Pittsburgh
University of Pittsburgh Medical Center, Pittsburgh
University of Maryland School of Medicine, Baltimore
John's Hopkins Hospital, Baltimore
Inova Transplant Center, Fairfax
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
University of Alabama-Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Ohio State University, Columbus
University Hospitals of Cleveland, Cleveland
The Cleveland Clinic Foundation, Cleveland
University of Michigan, Ann Arbor
University of Iowa Health Care, Iowa City
Heart Care Associates, Milwaukee
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
University of Chicago, Chicago
Washington University Hospital, St Louis
UT Southwestern, Dallas
Baylor College of Medicine, Pulmonary & Critical Care, Houston
The University of Texas Health Science Center at San Antonio, San Antonio
The Children's Hospital, Aurora
Pulmonary Hypertension Clinic, Aurora
Intermountain Medical Center, Murray
Arizona Pulmonary Specialist, Phoenix
University of Arizona Health Science Center, Tucson
West Los Angeles VA Healthcare Center, Los Angeles
Harbour-UCLA Medical Center, Torrance
University of California-San Francisco, San Francisco
Stanford University, Pulmonary and Critical Care, Palo Alto
UC Davis Medical Center, Sacramento
Legacy Clinic Northwest, Portland
University of Washington Medical Center, Seattle
Maine Medical Center, Portland
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
St. Vincent's Hospital, Sydney
The Prince Charles Hospital, Brisbane
The Alfred Hospital, Melbourne
Royal Perth Hospital, Perth
Medizinische Universität Innsbruck, Innsbruck
Universitaet Wien, Vienna
Hospital Erasme, Brussels
University Hospital Gasthuisberg, Leuven
Respiratory Research, Calgary
Hospital Cavale Blanche, Brest
Hospital Antoine Beclere, Clamart
Hospital Claude Huriez, Lille
Hôpital Louis Pradel, Lyon
Medizinische Hochschule Hannover, Hanover
Mater Misericordiae University Hospital Ltd, Dublin
Hadassah Ein-Kerem Medical Center, Jerusalem
Rabin Medical Center, Petah Tikva
Tel Hashomer Medical Center, Ramat Gan
Universita degli Studi Bologna, Bologna
"Universita La Sapienza Roma", Rome
Hospital Vrije Universiteit, Amsterdam
National Tuberculosis and Lung Disease Research Institute, Warsaw
Hospital Clinic of Barcelona, Barcelona
Hospital Valle Hebron, Barcelona
Hospital 12 de Octubre, Madrid
Papworth Hospital, Cambridge
Western Infirmary, Glasgow
Royal Free Hospital, London
Freeman Hospital, Newcastle
Vancouver Coastal Health Respiratory Clinic, Vancouver
Lab London Health Sciences Center, London
Toronto General Hospital, Toronto
SMBD Jewish General Hospital, Montreal
Lead Sponsor
United Therapeutics
INDUSTRY